Keros Therapeutics, Inc.

KROS ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2019

Total Assets: $11.0M

Liabilities Breakdown FY2019

Total Liabilities: $10.5M